Back to News
Market Impact: 0.3
Amneal Pharmaceuticals (AMRX) Q3 Earnings and Revenues Top Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Amneal Pharmaceuticals reported quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 by $0.02. Earnings were up from $0.17 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
AMRX0.65
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge